SARS-CoV-2-Mediated Lung Edema and Replication Are Diminished by Cystic Fibrosis Transmembrane Conductance Regulator

Jose M Honrubia1, Javier Gutierrez-Álvarez1, Alejandro Sanz-Bravo1

  • 1Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain.

Mbio
|January 10, 2023
PubMed

Insights

The envelope (E) protein

Area of Science:

  • Virology
  • Molecular Biology

Background:

  • Coronaviruses (CoVs) possess a PDZ-binding motif (PBM) in their envelope (E) protein, crucial for host cell interaction.
  • The PBMs of highly pathogenic human CoVs (SARS-CoV, MERS-CoV, SARS-CoV-2) function as virulence factors.
  • PDZ domains are key protein interaction modules involved in cellular function regulation.

Purpose of the Study:

  • To investigate the role of the E protein PBM in SARS-CoV and SARS-CoV-2 virulence.
  • To analyze the impact of different E protein PBMs on host gene expression.
  • To identify potential therapeutic targets for CoV infections.

Main Methods:

  • Construction of SARS-CoV mutants with altered E protein PBMs.
  • RNA sequencing of infected mouse lung tissues to analyze gene expression patterns.
  • In vitro and in vivo models to assess the efficacy of CFTR-modulating compounds.

Main Results:

  • E protein PBMs of SARS-CoV and SARS-CoV-2 dysregulated genes involved in ion transport and cell homeostasis.
  • Decreased expression of cystic fibrosis transmembrane conductance regulator (CFTR) mRNA was observed, correlating with edema.
  • Compounds enhancing CFTR expression and activity reduced SARS-CoV-2 replication and protected against infection in mice.

Conclusions:

  • The E protein PBM is a significant virulence factor for SARS-CoV and SARS-CoV-2.
  • Dysregulation of CFTR expression by the E protein PBM contributes to CoV-induced lung pathology.
  • Targeting CFTR offers a promising strategy for developing novel antiviral therapies against SARS-CoV-2.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
210
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
324
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
404
Transcellular Transport of Solutes01:23

Transcellular Transport of Solutes

Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
3.7K